SONIC HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.34 AUD | -1.50% |
|
+0.27% | -17.89% |
| Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
| Mar. 20 | Sonic Healthcare Limited agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million. | CI |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company benefits from high valuations in earnings multiples.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -17.89% | 8.25B | B+ | ||
| +39.20% | 3.57B | C+ | ||
| -39.11% | 2.46B | B- | ||
| -8.06% | 2.46B | - | ||
| -7.35% | 2.38B | B- | ||
| -12.61% | 1.81B | C- | ||
| -19.01% | 1.55B | A- | ||
| -40.66% | 1.21B | C+ | ||
| +7.56% | 1.11B | B+ | ||
| -15.34% | 1.03B | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SHL Stock
- Ratings Sonic Healthcare Limited
